drugset / Trial / NCT01367301

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

NCT01367301 ↗

NaSingle-groupOpen-labelTreatment

Summary

This pilot clinical trial studies radiation therapy, paclitaxel, and carboplatin in treating patients with uterine cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or stopping them from dividing. Giving radiation with chemotherapy may kill more tumor cells.

Timeline

Start
2011-07-08
Primary completion
2018-08-15
Completion
2018-08-15

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of accrual. PI left the institution”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Paclitaxel Small molecule — Intravenous